Seres Therapeutics, Inc.
8 clinical trials · Sponsor
◉ Watch Seres Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT (NCT04995653) | Seres Therapeutics, Inc. | 2021-11-24 |
| A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis (NCT03759041) | Seres Therapeutics, Inc. | 2018-12-19 |
| ECOSPOR IV: An Open-Label Study Evaluating SER-109 in Recurrent Clostridioides Difficile Infection (NCT03183141) | Seres Therapeutics, Inc. | 2017-10-23 |
Track Seres Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.